Last Price
347.32
Today's Change
+5.02 (1.46%)
Day's Change
343.32 - 352.56
Trading Volume
144,299
Market Cap
10 Billion
Shares Outstanding
31 Million
Avg Volume
385,606
Avg Price (50 Days)
337.68
Avg Price (200 Days)
378.13
PE Ratio
30.39
EPS
11.43
Earnings Announcement
10-Feb-2025
Previous Close
342.30
Open
344.09
Day's Range
343.325 - 352.565
Year Range
277.72 - 459.77
Trading Volume
144,299
1 Day Change
1.47%
5 Day Change
1.44%
1 Month Change
-3.05%
3 Month Change
3.45%
6 Month Change
-13.83%
Ytd Change
13.66%
1 Year Change
24.78%
3 Year Change
69.44%
5 Year Change
333.56%
10 Year Change
1149.83%
Max Change
1149.83%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.